Locations:
Search
Combination therapy improves outcomes, but lobular patients still do worse overall than ductal counterparts
Bringing empathy and evidence-based practice to addiction medicine
Supplemental screening for dense breasts
Combining advanced imaging with targeted therapy in prostate cancer and neuroendocrine tumors
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Benefits of neoadjuvant immunotherapy reflect emerging standard of care
Early results show strong clinical benefit rates
Phase 2 trials investigate sitagliptin and methimazole as adjuvant therapies
The shifting role of cell therapy and steroids in the relapsed/refractory setting
Radiation therapy helped shrink hand nodules and improve functionality
Standard of care is linked to better outcomes, but disease recurrence and other risk factors often drive alternative approaches
Advertisement
Advertisement